Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
---|
05/10/2001 | WO2001032749A1 Novel diamine, novel acid dianhydride, and novel polyimide composition formed therefrom |
05/10/2001 | WO2001032617A1 Process for the preparation of 7-azabicyclo[4.1.0]-hept-3-ene-3-carboxylic acid esters |
05/10/2001 | WO2001032603A1 Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same |
05/10/2001 | WO2001032602A1 Diaryl-enynes |
05/10/2001 | WO2001032596A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
05/10/2001 | WO2001032130A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
05/10/2001 | CA2390025A1 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
05/10/2001 | CA2389373A1 Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same |
05/10/2001 | CA2387660A1 Diaryl-enynes as glycine transport inhibitors |
05/09/2001 | EP1097919A2 Process for producing 4-amino-3-oxo-butanoic acid ester |
05/09/2001 | EP1097158A2 Ligands for metals and metal-catalyzed processes |
05/09/2001 | EP1097149A1 Bicyclohexane derivatives |
05/09/2001 | EP1097126A1 Crystalline salts of dodecyl 2-(n,n-dimethylamino)-propionate |
05/08/2001 | US6229045 Carboxylation of primary aliphatic alcohols in alkaline solution via contacting with a catalyst comprising cobalt, copper, cerium, iron, zinc, and/or zirconium |
05/08/2001 | US6229026 Reacting an isobenzofuran derivative with grignard reagents 4-halogen-fluorophenyl and 3-halogen-n,n-dimethylpropylamine; causing ring-closure of the product and conversion to 5-cyano derivative |
05/08/2001 | US6229020 Reacting n-succinimidyl and p-nitrophenyl cinnamate derivatives with physiologically active substance such as an amino acid; protecting amino or hydroxy groups for analysis of biological reactions by irradiation with light |
05/08/2001 | US6228985 Derivatives of aminobenzoic and aminobiphenylcarboxylic acids useful as anti-cancer agents |
05/08/2001 | US6228885 Fungicidal compositions based on (N-phenylacetyl-N-2,6-XYLYL)methyl alaninate |
05/08/2001 | CA2017746C A new phenylacetic derivative and process for their obtention |
05/03/2001 | WO2001030148A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
05/03/2001 | WO2001001569A3 Process for preparing (-)-(1s,4r) n-protected 4-amino-2-cyclopentene-1-carboxylate esters |
05/02/2001 | EP1095048A1 Process for preparing n-phosphonomethyl iminodiacetic acid |
05/02/2001 | EP1095011A1 Novel fluorescent lanthanide chelates |
05/02/2001 | EP1095010A1 Process for the preparation of gabapentin |
05/02/2001 | EP1095009A2 A process for the preparation of 4-carboxy- 5,8,11- tris(carboxymethyl)- 1-phenyl- 2-oxa- 5,8,11- triazatridecan- 13-oic acid |
05/02/2001 | EP0885185B1 Betaine gemini surfactants made from amines |
05/02/2001 | CN1293655A Bicyclo [2.2.1] heptanes and related compounds |
05/02/2001 | CN1293186A Process for preparing flufenamic acid |
05/02/2001 | CN1293067A Use of 4-(4-ethoxybenzyl)-3,6,9-tri(carboxymethyl)-3,6,9-triazohendecanedioic acid calcium composition |
05/02/2001 | CN1293036A Use of 4-(4-ethoxygenzyl)-3,6,9-tri(carboxymethyl)-3,6,9-triazohendecanedioic acid calcium composition |
05/02/2001 | CN1065240C Taxanes having butenyl substituted side-chain and pharmaceutical compositions containing them |
05/02/2001 | CN1065237C Cyclopentane-and-cyclo pentene-beta-amino acids |
05/02/2001 | CN1065236C Method for synthesising betaine hydrochloride |
05/01/2001 | US6225625 Signal detection methods and apparatus |
05/01/2001 | CA2111169C Phenylacetic acid derivatives, process for the preparation thereof and corresponding use |
04/26/2001 | WO2001028978A1 Bicyclic amino acids as pharmaceutical agents |
04/26/2001 | WO2001028494A2 Nordihydroguaiaretic derivatives for use in treatment of tumors |
04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
04/25/2001 | EP1093451A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines |
04/24/2001 | US6222052 Process for preparing optically active 2-amino-ω-oxoalkanoic acid derivatives |
04/24/2001 | US6222013 Esterifying amino acid or peptide by mixing with alkanol and chlorosulfonic acid; alcohol reacts with chlorosulfonic acid to form a hydrosulfate which then reacts with amino acid or peptide for form corresponding ester |
04/24/2001 | US6221367 Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex |
04/24/2001 | US6221196 Wetting a support element in region of adhesion zone with liquid composition of adhesion promoter to form coating; solidifying coating; shaping and solidifying elastomeric material by vulcanization |
04/19/2001 | WO2001027090A1 m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRINαvβ3 ANTAGONISM |
04/19/2001 | WO2001027074A1 Preparation of amino-protected lysine derivatives |
04/19/2001 | WO2001027069A1 Mixed-metal chelates and process for the preparation thereof |
04/19/2001 | CA2392209A1 M-substituted benzoic acid derivatives having integrin .alpha.v.beta.3 antagonistic activity |
04/19/2001 | CA2386998A1 Preparation of amino-protected lysine derivatives |
04/18/2001 | EP1091929A2 Secondary aspartic acid amide esters |
04/18/2001 | EP1091927A1 Process for preparation of substituted propenoic acid esters |
04/17/2001 | US6218566 Process for manufacturing of L-DOPA ethyl ester |
04/17/2001 | US6218559 Hydrogenation catalyst, process for the preparation thereof and hydrogenation process |
04/17/2001 | US6218432 Diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
04/17/2001 | US6218370 Useful for cell transfection |
04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
04/17/2001 | CA2020142C Derivatized dtpa complexes |
04/12/2001 | WO2001025172A1 A method for preparing and screening one or more compounds |
04/12/2001 | WO2000076958A3 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
04/12/2001 | CA2385715A1 A method for preparing and screening one or more compounds |
04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
04/11/2001 | EP1090151A1 Process for separation of heavy metals from residues by use of of ethylenediamine-disuccinic acid (edds) complexant |
04/11/2001 | EP1090007A2 Cinoxacin lanthanide chelates and their use as biomolecular probes |
04/11/2001 | EP0914315B1 Stable, non-hygroscopic salts of l(-)carnitine and alkanoyl l(-)carnitines, a process for their preparation and solid, orally administrable compositions containing such salts |
04/11/2001 | EP0815071B1 Liposomogenic uv absorbers |
04/11/2001 | CN1291182A Process for producing highly pure tetrasodium salt of ethylenediaminetetracetic acid |
04/11/2001 | CN1064352C Novel cyloakyl derivatives and inhibitors of bone resorption and vitronection receptor antagonists |
04/10/2001 | US6214874 Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N |
04/05/2001 | WO2001023497A1 Organic electroluminescent element |
04/05/2001 | WO2001023354A2 Trifluoromethyl-substituted spirocyclic ketoenols and use thereof as pesticides and herbicides |
04/05/2001 | WO2001023346A2 Process for phenylacetic acid derivatives |
04/05/2001 | WO2000050378A3 Synthesis of nitroalcohol diastereomers |
04/05/2001 | DE19946625A1 Trifluormethylsubstituierte spirocyclische Ketoenole Trifluoromethyl-substituted spirocyclic ketoenols |
04/05/2001 | CA2384501A1 Trifluoromethyl-substituted spirocyclic ketoenols |
04/04/2001 | EP1087943A1 Therapeutic biaryl derivatives |
04/04/2001 | EP1087935A1 Anthracene derivatives as anti-cancer agents |
04/04/2001 | CN1290248A Serine carbonates |
04/04/2001 | CN1290246A Method for hydrogenating 5-nitrosalicylic acids |
04/04/2001 | CN1289764A Process for preparing ethyl p-dimethylaminobenzoate |
04/03/2001 | US6211234 Substituted phenyl compounds |
03/29/2001 | WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's) |
03/28/2001 | EP1086944A2 Amino acid derivative composition and process for producing an amino acid derivative |
03/28/2001 | CN1288884A Glycine purifying and closed production process |
03/27/2001 | US6207854 Cyclopropanecarboxaldehyde is reacted with malonic acid and a source of ammonia, contacting ester with enantiomerically pure acid tartaric acid, dibenzoyltartaric acid and mandelic acid to obtain a diastereomeric salt of the 3-cpa ester, |
03/27/2001 | US6207828 Process for making 2-(trihaloacetyl)-3-(substituted amino)-2-propenoates |
03/27/2001 | US6207010 Preparation and use of iminodisuccinic acid salts |
03/27/2001 | CA2198258C Amino acid chelates having improved palatability |
03/22/2001 | WO2001019787A1 OPTICALLY ACTIVE α-AMINONITRILE AND PROCESS FOR PRODUCING α-AMINO ACID |
03/22/2001 | WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
03/22/2001 | WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
03/22/2001 | WO2001019770A2 Rxr modulators with improved pharmacologic profile |
03/22/2001 | WO2001002332A3 Process for the preparation of 3,3-dimethylbutanal |
03/22/2001 | CA2383565A1 Rxr modulators with improved pharmacologic profile |
03/21/2001 | EP1084137A1 Peptide inhibitors of hepatitis c virus ns3 protease |
03/21/2001 | EP1083889A2 Method for treating neurodegenerative disorders |
03/21/2001 | CN1063441C 1,3-Oxazin-4-one derivatives process and intermediates for their preparation and their use as herbicides |
03/21/2001 | CN1063431C Method for preparing phenyl alanine without water crystal |
03/21/2001 | CN1063430C Ethanolamine derivatives |
03/20/2001 | US6204292 Bicyclic metabotropic glutamate receptor ligands |
03/20/2001 | US6204290 Treating a hypercholesteremic, thrombotic, oxidative, inflammatory, or immunoregulatory disease |
03/20/2001 | US6204238 Fatty acid derivatives and their use as surfactants in detergents and cleaners |